D3A.029
Benign carcinoid tumor of the large intestine, unspecified portion
Clinical Classification Guidelines
Inclusion Terms
- Benign carcinoid tumor of the colon NOS
Medical Intelligence & Overview
A benign carcinoid tumor of the large intestine, specifically the colon, is a non-cancerous growth that originates from neuroendocrine cells. These tumors are typically slow-growing and may initially cause no symptoms, but understanding their nature is important for management and monitoring. This guide explains what a benign carcinoid tumor of the colon is, its causes, symptoms, how it is diagnosed, and treatment options.
Causes & Symptoms
Clinical Causes: Genetic factors that influence cell growth Unknown precise etiology, as with many neuroendocrine tumors Potential association with other medical conditions affecting the colon Environmental factors and lifestyle may play a role, but evidence is limited
Key Symptoms: Often asymptomatic in early stages Changes in bowel habits, such as diarrhea or constipation Abdominal pain or discomfort Unexplained weight loss in some cases Rectal bleeding or blood in stool Nausea or vomiting, if the tumor obstructs the bowel A palpable mass in the abdomen in larger tumors
Diagnostic & Treatment
Diagnosis Path: Endoscopic procedures like colonoscopy to visualize the inner lining of the colon and obtain tissue samples (biopsy) Imaging tests such as CT scans, MRI, or somatostatin receptor scintigraphy to locate tumors and assess their size and spread Histopathological examination of biopsy tissue confirms the neuroendocrine origin and benign nature Laboratory tests measuring specific hormones or markers may assist in diagnosis, although less common in benign tumors
Treatment Protocols: Endoscopic resection for smaller tumors confined to the mucosa Surgical removal of the affected segment of the colon in larger or more invasive tumors Regular follow-up with colonoscopy and imaging to monitor for recurrence or growth In cases where the tumor is completely removed, prognosis is generally favorable Additional treatments are rarely necessary unless histology indicates malignant potential or if complications develop
Clinical Advice & FAQs
Billing Guidance
Is D3A.029 a billable ICD-10 code?
Yes, D3A.029 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D3A.029?
Clinical documentation must specify the nature of Benign carcinoid tumor of the large intestine, unspecified portion and any associated comorbidities for accurate reporting.
Cite this Clinical Reference